Mahkam Mehrdad, Vakhshouri Laleh
Chemistry Department, Azarbaijan University of Tarbiat Moallem, Tabriz, Iran.
Int J Mol Sci. 2010 Apr 12;11(4):1546-56. doi: 10.3390/ijms11041546.
The preparation, characterization, and in vitro release of 5-aminosalicylic acid (5-ASA) from methacrylic acid (MAA)/perlite composites (APC) prepared via a sol-gel route are reported. The free-radical graft polymerization of methacrylic acid (MAA) onto perlite particles was studied experimentally. The grafting procedure consisted of surface activation with 3-(trimethoxysilyl) propyl methacrylate (TSPA), followed by free-radical graft polymerization of methacrylic acid (MAA) in ethyl acetate with 2,2'-azobisisobutyronitrile (AIBN) initiator. The composition of the composites hybrid materials was determined by FTIR spectroscopy. Equilibrium swelling studies were carried out in enzyme-free simulated gastric and intestinal fluids (SGF and SIF, respectively). The dried composites were immersed in a saturated solution of 5-ASA in water overnight and dried over a period of three days at room temperature and the in vitro release profiles were established separately in both (SGF, pH 1) and (SIF, pH 7.4). The 5-ASA concentration of the solution was measured using a UV-Vis spectrophotometer (205 nm) at different time intervals. The in vitro drug release test revealed that the release rate of 5-ASA in buffer solutions increased with the silica content in the composites; on the contrary, the increase of the content of 3-(trimethoxysilyl)propyl methacrylate (TSPA), a coupling agent, decreased the drug release rate.
报道了通过溶胶 - 凝胶法制备的甲基丙烯酸(MAA)/珍珠岩复合材料(APC)中5 - 氨基水杨酸(5 - ASA)的制备、表征及体外释放情况。对甲基丙烯酸(MAA)在珍珠岩颗粒上的自由基接枝聚合进行了实验研究。接枝过程包括用甲基丙烯酸3 - (三甲氧基甲硅烷基)丙酯(TSPA)进行表面活化,随后在乙酸乙酯中用2,2'-偶氮二异丁腈(AIBN)引发剂进行甲基丙烯酸(MAA)的自由基接枝聚合。通过傅里叶变换红外光谱(FTIR)确定复合材料杂化材料的组成。分别在无酶模拟胃液和肠液(分别为SGF和SIF)中进行平衡溶胀研究。将干燥的复合材料在5 - ASA的饱和水溶液中浸泡过夜,然后在室温下干燥三天,并分别在(SGF,pH 1)和(SIF,pH 7.4)中建立体外释放曲线。在不同时间间隔使用紫外 - 可见分光光度计(205 nm)测量溶液中5 - ASA的浓度。体外药物释放试验表明,缓冲溶液中5 - ASA的释放速率随复合材料中二氧化硅含量的增加而增加;相反,偶联剂甲基丙烯酸3 - (三甲氧基甲硅烷基)丙酯(TSPA)含量的增加降低了药物释放速率。